1. Home
  2. VXRT vs ECCC Comparison

VXRT vs ECCC Comparison

Compare VXRT & ECCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VXRT
  • ECCC
  • Stock Information
  • Founded
  • VXRT N/A
  • ECCC N/A
  • Country
  • VXRT United States
  • ECCC United States
  • Employees
  • VXRT N/A
  • ECCC N/A
  • Industry
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • ECCC Trusts Except Educational Religious and Charitable
  • Sector
  • VXRT Health Care
  • ECCC Finance
  • Exchange
  • VXRT Nasdaq
  • ECCC Nasdaq
  • Market Cap
  • VXRT N/A
  • ECCC N/A
  • IPO Year
  • VXRT N/A
  • ECCC N/A
  • Fundamental
  • Price
  • VXRT $0.32
  • ECCC $23.28
  • Analyst Decision
  • VXRT Strong Buy
  • ECCC
  • Analyst Count
  • VXRT 2
  • ECCC 0
  • Target Price
  • VXRT $3.00
  • ECCC N/A
  • AVG Volume (30 Days)
  • VXRT 6.8M
  • ECCC N/A
  • Earning Date
  • VXRT 08-07-2025
  • ECCC N/A
  • Dividend Yield
  • VXRT N/A
  • ECCC N/A
  • EPS Growth
  • VXRT N/A
  • ECCC N/A
  • EPS
  • VXRT N/A
  • ECCC N/A
  • Revenue
  • VXRT $47,395,000.00
  • ECCC N/A
  • Revenue This Year
  • VXRT N/A
  • ECCC N/A
  • Revenue Next Year
  • VXRT N/A
  • ECCC N/A
  • P/E Ratio
  • VXRT N/A
  • ECCC N/A
  • Revenue Growth
  • VXRT 433.43
  • ECCC N/A
  • 52 Week Low
  • VXRT $0.26
  • ECCC N/A
  • 52 Week High
  • VXRT $1.07
  • ECCC N/A
  • Technical
  • Relative Strength Index (RSI)
  • VXRT 30.00
  • ECCC 62.71
  • Support Level
  • VXRT $0.42
  • ECCC $23.22
  • Resistance Level
  • VXRT $0.60
  • ECCC $23.34
  • Average True Range (ATR)
  • VXRT 0.06
  • ECCC 0.09
  • MACD
  • VXRT -0.03
  • ECCC -0.02
  • Stochastic Oscillator
  • VXRT 10.26
  • ECCC 77.70

About VXRT Vaxart Inc

VAXART INC

About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.

Share on Social Networks: